The Klinique Medical Clinic Public Company Limited (BKK: KLINIQ)
Thailand
· Delayed Price · Currency is THB 36.50
0.00 (0.00%)
Sep 6, 2024, 4:39 PM ICT
KLINIQ Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2016 | 2015 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '16 Dec 31, 2016 | 2015 - 2013 |
| Operating Revenue | 2,626 | 2,285 | 1,639 | 949.93 | 1,001 | 644.33 | Upgrade
|
| Other Revenue | - | - | - | - | - | 6.64 | Upgrade
|
| Revenue | 2,626 | 2,285 | 1,639 | 949.93 | 1,001 | 650.97 | Upgrade
|
| Revenue Growth (YoY) | 33.09% | 39.41% | 72.54% | -5.06% | 53.70% | 0.11% | Upgrade
|
| Cost of Revenue | 1,265 | 1,050 | 716.07 | 391.16 | 406.55 | 509.65 | Upgrade
|
| Gross Profit | 1,361 | 1,235 | 922.97 | 558.77 | 594 | 141.32 | Upgrade
|
| Selling, General & Admin | 1,017 | 903.07 | 674.28 | 407.68 | 431.13 | 103.61 | Upgrade
|
| Other Operating Expenses | -12.23 | -13.2 | -7.06 | -2.15 | -6.07 | - | Upgrade
|
| Operating Expenses | 1,005 | 889.88 | 667.22 | 405.53 | 425.06 | 103.61 | Upgrade
|
| Operating Income | 356.42 | 345.16 | 255.75 | 153.24 | 168.94 | 37.71 | Upgrade
|
| Interest Expense | -20.08 | -15.1 | -10.66 | -4.32 | -5.93 | -0.33 | Upgrade
|
| Interest & Investment Income | 20.04 | 20.17 | 1.11 | 0.06 | 2.58 | - | Upgrade
|
| Pretax Income | 356.38 | 350.22 | 246.2 | 148.98 | 165.6 | 37.37 | Upgrade
|
| Income Tax Expense | 58.08 | 61.6 | 40.71 | 19.73 | 20.9 | 4.71 | Upgrade
|
| Earnings From Continuing Operations | 298.3 | 288.62 | 205.49 | 129.26 | 144.69 | 32.66 | Upgrade
|
| Net Income | 298.3 | 288.62 | 205.49 | 129.26 | 144.69 | 32.66 | Upgrade
|
| Net Income to Common | 298.3 | 288.62 | 205.49 | 129.26 | 144.69 | 32.66 | Upgrade
|
| Net Income Growth | 21.76% | 40.45% | 58.98% | -10.67% | 342.97% | -49.01% | Upgrade
|
| Shares Outstanding (Basic) | 220 | 220 | 170 | 160 | 160 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 220 | 220 | 170 | 160 | 160 | 53 | Upgrade
|
| Shares Change (YoY) | 10.17% | 29.64% | 6.06% | - | 202.11% | 461.02% | Upgrade
|
| EPS (Basic) | 1.36 | 1.31 | 1.21 | 0.81 | 0.90 | 0.62 | Upgrade
|
| EPS (Diluted) | 1.36 | 1.31 | 1.21 | 0.81 | 0.90 | 0.62 | Upgrade
|
| EPS Growth | 10.53% | 8.34% | 49.89% | -10.67% | 46.62% | -90.91% | Upgrade
|
| Free Cash Flow | -75.17 | 19.39 | 182.17 | 165.64 | 99.93 | -2.48 | Upgrade
|
| Free Cash Flow Per Share | -0.34 | 0.09 | 1.07 | 1.04 | 0.62 | -0.05 | Upgrade
|
| Dividend Per Share | 0.750 | 1.300 | 0.500 | 0.356 | 0.300 | 0.325 | Upgrade
|
| Dividend Growth | -3.85% | 160.00% | 40.33% | 18.77% | -7.69% | -18.75% | Upgrade
|
| Gross Margin | 51.84% | 54.05% | 56.31% | 58.82% | 59.37% | 21.71% | Upgrade
|
| Operating Margin | 13.57% | 15.11% | 15.60% | 16.13% | 16.88% | 5.79% | Upgrade
|
| Profit Margin | 11.36% | 12.63% | 12.54% | 13.61% | 14.46% | 5.02% | Upgrade
|
| Free Cash Flow Margin | -2.86% | 0.85% | 11.11% | 17.44% | 9.99% | -0.38% | Upgrade
|
| EBITDA | 442.03 | 450.75 | 329 | 205.17 | 210.04 | 79.69 | Upgrade
|
| EBITDA Margin | 16.83% | 19.73% | 20.07% | 21.60% | 20.99% | 12.24% | Upgrade
|
| D&A For EBITDA | 85.62 | 105.59 | 73.26 | 51.93 | 41.1 | 41.98 | Upgrade
|
| EBIT | 356.42 | 345.16 | 255.75 | 153.24 | 168.94 | 37.71 | Upgrade
|
| EBIT Margin | 13.57% | 15.11% | 15.60% | 16.13% | 16.88% | 5.79% | Upgrade
|
| Effective Tax Rate | 16.30% | 17.59% | 16.53% | 13.24% | 12.62% | 12.59% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 650.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.